Search Orphan Drug Designations and Approvals
-
| Generic Name: | human leukocyte-derived cytokine mixture |
|---|---|
| Date Designated: | 07/07/2005 |
| Orphan Designation: | Neoadjuvant therapy in patients with squamous cell carcinoma of the head and neck |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
IRX Therapeutics, Inc. Suite 2100 Brooklyn, New York 11220 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







